Perspective on salience processing
News Nov 25, 2014
The journal Nature Reviews Neuroscience features an opinion article authored by Lucina Q. Uddin, assistant professor of Psychology in the University of Miami College of Arts and Sciences.
Uddin’s article “Salience Processing and Insular Cortical Function and Dysfunction” reviews recent findings about the neuroscience of how the brain selects certain things out of the environment that are "salient" for an individual. The findings show that dysfunction of salience processing systems in the brain is linked to disorders such as autism, psychosis, and dementia.
“The take home message of the article is that a complex and multi-purpose brain structure called the insula seems to be very critical for responding to salient stimuli.” Uddin said. “When this brain region is not functioning properly, one can see striking effects on different aspects of several prevalent brain disorders,” Uddin said.
The article highlights that the insular cortex is not homogenous, it can be separated into different subdivisions. The function of one of these subdivisions, in particular, is important for orchestrating activity in other brain regions that are involved in guiding attention.
“The next step will be to carefully characterize insula dysfunction as it relates to major brain disorders,” Uddin said.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Lucina Q. Uddin. Salience processing and insular cortical function and dysfunction. Nature Reviews Neuroscience, Published Online November 19 2014. doi: 10.1038/nrn3857
Synaptotagmin 7 Ensures Efficiency of Inhibitory Signal TransmissionNews
Researchers at IST Austria define function of an enigmatic synaptic protein, synaptotagmin 7.READ MORE
Molecules in Spit Could Help Diagnose ConcussionsNews
Diagnosing a concussion can sometimes be a guessing game, but clues taken from small molecules in saliva may be able to help diagnose and predict the duration of concussions in children, according to Penn State College of Medicine researchers.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE